Ritodrine-Induced Hypokalemia by Sohn, Il-Suk et al.
 
 
  295
IMAGES IN CARDIOVASCULAR MEDICINE 
DOI 10.4070 / kcj.2009.39.7.295 
Print ISSN 1738-5520 / On-line ISSN 1738-5555
Copyright ⓒ 2009 The Korean Society of Cardiology
 
Ritodrine-Induced Hypokalemia 
 
Il-Suk Sohn, MD, Jeong-Hwan Park, MD, Jin-Man Cho, MD and Chong-Jin Kim, MD 
Department of Cardiology, Kyunghee University East-West Neo Medical Center, Seoul, Korea 
 
A 31-year-old woman presented with chest discom-
fort in the 22nd week of pregnancy. She had been treated 
with an intravenous infusion of ritodrine hydrochloride 
(0.25 mg/min) for preterm labor the prior day. On phy-
sical examination, the body temperature was 36.3℃, the 
blood pressure was 117/68 mmHg, the pulse was 96 
beats/min, and the respiratory rate was 20 breaths/min. 
Electrocardiography (ECG) showed ST-T changes resem-
bling ischemia in the inferolateral leads (Fig. A) with a 
heart rate of 98 beats/min. An ECG taken the preceding 
day revealed no ST-T changes (Fig. B). The ECG in 
limb lead II showed flattening of the T wave, slight ST 
depression, and prominent U waves, as in hypokalemia 
(Fig. C). QT prolongation and a U wave were promi-
nent in the precordial leads (Fig. A). Urgent echocar-
diography to detect cardiac function and ischemic changes 
showed normal cardiac function without wall motion 
abnormalities. After discontinuing the ritodrine infusion, 
the ECG returned to normal the following day (Fig. D 
and E) and her chest discomfort resolved. Her serum 
potassium level, which had been 4.1 mEq/L the previous 
day, was 3.4 mEq/L, and returned to 4.1 mEq/L after 
discontinuation of the ritodrine infusion. The serum 
fasting glucose level was 81 mg/dL, and 80 mg/dL the 
preceding day. The plasma calcium was 8.8 mg/dL and 
the magnesium level was 1.9 mg/dL. 
Ritodrine, a beta 2-selective adrenergic drug, is used 
as a tocolytic drug for management of preterm labor.
1) 
One of the most common side effects of ritodrine is hy-
pokalemia because of a marked increase in plasma insu-
lin, which results in stimulation of the cellular uptake of 
potassium.
2)3) Ritodrine-induced hypokalemia shows ty-
pical ECG changes resembling hypokalemia typical of 
other causes. As in this case, typical ECG changes asso-
ciated with a ritodrine infusion may not be compatible 
with the absolute serum level of potassium. 
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Fig. Electrocardiography (ECG) showed ST-T changes resembling ischemia in the inferolateral leads (A) with a heart rate of 98 beats/
min. The ECG obtained the preceding day revealed no ST-T changes (B). The ECG in limb lead II showed flattening of the T wave, slight ST 
depression, and a prominent U wave (arrows, C). After discontinuing the ritodrine infusion, the ECG returned to normal the following day
(D and E). 
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